Showing 1 to 2 of 2 results
A new strategy to produce drug carriers for treating cancer with an efficiency rate as high as 80% has been devised by researchers at CityU.
CityU has contributed to the development of a new molecular classification system for colorectal cancer with highly significant potential for treatment and prognosis.